Health Canada approves abortion pill—Will controversy follow?

By qqtqtqt etqt
Share

You may have recently heard that the abortion pill has recently been approved by Health Canada. Known more appropriately as drug RU-486, this medication has been cleared for Canada, allowing women to take a pill that induces a miscarriage.

RELATED TOPIC: Ontario’s home healthcare system is failing—What needs to change?

The RU-486 medication has already been available in 57 other countries. Specifically, the drug has been readily available for a quarter of a century in France and Britain. The pill has been available in the United States since 2000.

Made by Linepharma International Limited, the pill will be sold under the brand name Mifegymiso throughout Canada. However, while some countries do allow for the drug to be dispensed by pharmacists, Health Canada has made a ruling that will require women to get a prescription from their doctor before they can make a purchase.

A spokesperson for Federal Health Minister Rona Ambrose has had this to say on the issue: “Drug approval decisions are arms-length decisions made by Health Canada officials based on analysis by Health Canada scientists.”

RELATED TOPIC: The 5 Canadian digital health companies to watch and why

The RU-486 drug works by blocking the production of progesterone, which is a hormone that is needed in order for a pregnancy to take place. Experts in the medical reproductive industry have referred to the pill as the best known option for abortion. Therefore, getting the drug approved in Canada has been on the agenda for quite some time.

However, not everyone in the country is in favor for the abortion pill. As you can imagine, the approval of this drug has caused a bit of a stir in Canada.

Particularly, Campaign Life Coalition, an anti-abortion rights group, has recently called for the federal government and Ambrose to stop distributing the drug. As well, other pro-life organizations have jumped on the bandwagon, hoping to get the legal ruling overturned.

Furthermore, National President of Campaign Life Coalition Jim Hughes has said this on the matter: “We have fought against this drug coming into Canada since 1999 in order to safeguard the health of women and save unborn children from early deaths.”

This quite seems a little ironic, though. For starters, a man is implying he knows what’s best for women. But shouldn’t it be believed that a woman knows what’s best for her and her body? Sure, there is definitely a gray area to this whole subject, but at the end of the day, should women be responsible for their own decisions, as well as their own bodies?

RELATED TOPIC: Doctor’s admit to spreading infections at work—Taking sick days are important

For the latest news in the healthcare industry, visit our sister brand Healthcare Global.

[SOURCE: Global News]

Let's Connect!

 

Read the latest edition of Business Review Canada!

Share

Featured Articles

What is Nestlé CEO Laurent Freixe’s Action Plan?

Newly appointed CEO sets out action plan involving separating water brands into standalone business and boosting advertising and marketing spend

Will Mulberry Turn a New Leaf Under CEO Andrea Baldo?

International British luxury brand cuts quarter of head office staff as newly appointed CEO conducts strategic review

Female Board Members of Biggest UK Companies Paid 69% Less

Female board members of FTSE 100 companies are paid 69% less than male counterparts, as they find themselves frozen out of the biggest roles

Is This the Next CEO of LVMH?

Leadership & Strategy

How Burberry’s New CEO Is Going Back to Basics

Leadership & Strategy

Is Bayer CEO Bill Anderson Running Out of Time?

Leadership & Strategy